文献速递重症综合管理与镇静镇痛

实验性人内毒素血症对免疫细胞功能的长期影响:与脓毒症的异同

Long-Term Effects of Experimental Human Endotoxemia on Immune Cell Function: Similarities and Differences With Sepsis.
PubMed 文献 · Shock · 2019-01-01
一句话结论实验性内毒素血症20天后仍可见中间型单核细胞增多且HLA表达降低、效应CD8细胞增多,后者与脓毒症患者相似,或可用于脓毒症免疫治疗研究。

本研究对健康受试者给予内毒素1 ng/kg,于4小时、2天和20天后用流式细胞术分析固有与适应性免疫系统组成,并与脓毒症休克患者发病后9天内的免疫组成比较。实验性内毒素血症导致中间型单核细胞绝对数增加,且20天后其人类白细胞抗原表达降低,这些变化与脓毒症休克患者不同。另一长期效应是效应CD8细胞数量升高、增殖和表达细胞因子的CD8细胞百分比增加,这些现象在脓毒症患者中也存在。结论认为,尽管存在相当大差异,实验性内毒素血症捕获了脓毒症免疫学的若干长期方面,尤其是CD8 T细胞行为,可能有助于开发脓毒症新疗法。

要点

  • 健康受试者接受内毒素1 ng/kg后20天,中间型单核细胞绝对数仍增加且人类白细胞抗原表达降低,此变化与脓毒症休克患者不同。
  • 实验性内毒素血症后效应CD8细胞数量升高、增殖和表达细胞因子的CD8细胞百分比增加,这些现象在脓毒症患者中也存在。
  • 实验性内毒素血症与脓毒症休克患者免疫组成存在若干差异和相似之处,CD8 T细胞行为是两者相似的长期方面。
  • 作者认为实验性内毒素血症捕获了脓毒症免疫学的若干长期方面,可能最终有助于开发脓毒症新疗法。

适用人群与场景

  • 健康受试者接受内毒素1 ng/kg攻击,于4小时、2天和20天后分析免疫组成。
  • 对照人群为脓毒症休克患者,比较其发病后前9天内的免疫组成。

研究设计与关键结果

  • 研究类型为实验性人内毒素血症免疫学观察研究,健康受试者接受内毒素1 ng/kg,于4小时、2天和20天后用流式细胞术分析固有与适应性免疫系统,并与脓毒症休克患者发病后前9天免疫组成比较。
  • 实验性内毒素血症导致中间型单核细胞绝对数增加,且20天后其人类白细胞抗原表达降低,这些变化与脓毒症休克患者观察到的不同。
  • 实验性内毒素血症的另一长期效应为效应CD8细胞数量升高、增殖和表达细胞因子的CD8细胞百分比增加,这些现象在脓毒症患者中也存在。

证据类型、等级与局限

  • 证据类型为实验性人内毒素血症观察研究,设脓毒症休克患者免疫组成对照。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管存在相当大差异,实验性内毒素血症捕获了脓毒症免疫学的若干长期方面,尤其是CD8 T细胞行为,可能最终有助于开发脓毒症新疗法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is the cause of more than 5.3 million deaths per year, and novel immunotherapeutic strategies are highly warranted. Human models that mirror sepsis immunology are instrumental to this aim. The response to endotoxin in humans during the first 24 h captures many hallmarks of the inflammatory response observed in sepsis. However, the long-term immunologic effects of human experimental endotoxemia have been sparsely studied and could be determinant for the use of this model in sepsis therapy research. In the present work, we studied the immune-composition of healthy subjects challenged with endotoxin (1 ng/kg) 4 h, 2 days, and 20 days post administration by flow cytometry to study the effects on innate and adaptive immune system, and compared it with the immune-composition in patients during the first 9 days after onset of septic shock. We found several differences and similarities between these groups. Experimental endotoxemia resulted in an increase in absolute numbers of intermediate monocytes, which also displayed lower human leucocyte antigen expression 20 days post endotoxin. These changes differed with those observed in septic shock patients. Another long-term effect of experimental endotoxemia was elevated numbers of effector CD8 cells and an increased percentage of proliferating and cytokine expressing CD8 cells, and these phenomena were also present in sepsis patients. In conclusion, despite considerable differences, experimental endotoxemia captures several long-term aspects of sepsis immunology, specifically the behavior of CD8 T cells, which may eventually aid the development of new therapies for sepsis patients.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Rodriguez-Rosales YA, Kox M, van Rijssen E, et al. Long-Term Effects of Experimental Human Endotoxemia on Immune Cell Function: Similarities and Differences With Sepsis. Shock. 2019. PMID: 30124597. doi:10.1097/SHK.0000000000001222

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。